These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17227473)

  • 1. Non-SCN5A related Brugada syndromes: verification of normal splicing and trafficking of SCN5A without exonic mutations.
    Nakano Y; Tashiro S; Kinoshita E; Kinoshita-Kikuta E; Takenaka S; Miyoshi M; Ogi H; Sakoda E; Oda N; Suenari K; Tonouchi Y; Okimoto T; Hirai Y; Miura F; Yamaoka K; Koike T; Chayama K
    Ann Hum Genet; 2007 Jan; 71(Pt 1):8-17. PubMed ID: 17227473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome].
    Yuan BB; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):404-7. PubMed ID: 19100032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
    Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy.
    Rossenbacker T; Schollen E; Kuipéri C; de Ravel TJ; Devriendt K; Matthijs G; Collen D; Heidbüchel H; Carmeliet P
    J Med Genet; 2005 May; 42(5):e29. PubMed ID: 15863661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome.
    Hong K; Guerchicoff A; Pollevick GD; Oliva A; Dumaine R; de Zutter M; Burashnikov E; Wu YS; Brugada J; Brugada P; Brugada R
    J Mol Cell Cardiol; 2005 Apr; 38(4):555-60. PubMed ID: 15808832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
    Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ
    Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational screening of SCN5A linked disorders in Polish patients and their family members.
    Moric-Janiszewska E; Herbert E; Cholewa K; Filipecki A; Trusz-Gluza M; Wilczok T
    J Appl Genet; 2004; 45(3):383-90. PubMed ID: 15306732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
    Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
    Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M; Nakamura K; Kusano KF; Morita H; Nakagawa K; Tanaka M; Tada T; Toh N; Nishii N; Nagase S; Hata Y; Kohno K; Miura D; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):389-95. PubMed ID: 20625312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
    Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
    Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.
    Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW
    Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
    Amin AS; Boink GJ; Atrafi F; Spanjaart AM; Asghari-Roodsari A; Molenaar RJ; Ruijter JM; Wilde AA; Tan HL
    Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in domain I of SCN5A cause Brugada syndrome.
    Vatta M; Dumaine R; Antzelevitch C; Brugada R; Li H; Bowles NE; Nademanee K; Brugada J; Brugada P; Towbin JA
    Mol Genet Metab; 2002 Apr; 75(4):317-24. PubMed ID: 12051963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel sodium channel SCN5A mutations in Brugada syndrome patients from Greece.
    Kotta CM; Anastasakis A; Gatzoulis K; Manolis AS; Stefanadis C
    Int J Cardiol; 2010 Nov; 145(1):45-8. PubMed ID: 19406494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome.
    Santos LF; Rodrigues B; Moreira D; Correia E; Nunes L; Costa A; Elvas L; Pereira T; Machado JC; Castedo S; Henriques C; Matos A; Santos JO
    Europace; 2012 Jun; 14(6):882-8. PubMed ID: 22277643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOG1: a new susceptibility gene for Brugada syndrome.
    Kattygnarath D; Maugenre S; Neyroud N; Balse E; Ichai C; Denjoy I; Dilanian G; Martins RP; Fressart V; Berthet M; Schott JJ; Leenhardt A; Probst V; Le Marec H; Hainque B; Coulombe A; Hatem SN; Guicheney P
    Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural myocardial abnormalities in asymptomatic family members with Brugada syndrome and SCN5A gene mutation.
    Frustaci A; Russo MA; Chimenti C
    Eur Heart J; 2009 Jul; 30(14):1763. PubMed ID: 19411664
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
    Remme CA; Wilde AA; Bezzina CR
    Trends Cardiovasc Med; 2008 Apr; 18(3):78-87. PubMed ID: 18436145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.